This simply proves that big companies with huge overheads are poor at innovation when measured by carrying costs. Small VC funded companies innovate successfully for a tiny fraction of the costs of big pharma. The urban myth perpetuates and big pharma likes that to support pricing decisions.
http://lnkd.in/dWU3hVf
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022